Articles
Perspectives on regulatory status of moringa products and unwarranted health claims
Article number
1306_20
Pages
163 – 170
Language
English
Abstract
This review provides perspectives on the current regulatory status of moringa (Moringa oleifera) products in selected countries and warrants caution against moringa retailers making false and unjustified health claims for their products.
Furthermore, the recent ban on the sale of moringa products in Brazil is discussed.
Lastly, clarification is given on a recent ruling in the European Union (EU) to not allow Moringa stenopetala, a different species from the family moringaceae, to be sold and classified as a Traditional Food.
Suggestions for appropriate labeling of moringa products and a realistic perspective on dosage, and subsequent potential benefit from such dosages, are provided.
Furthermore, the recent ban on the sale of moringa products in Brazil is discussed.
Lastly, clarification is given on a recent ruling in the European Union (EU) to not allow Moringa stenopetala, a different species from the family moringaceae, to be sold and classified as a Traditional Food.
Suggestions for appropriate labeling of moringa products and a realistic perspective on dosage, and subsequent potential benefit from such dosages, are provided.
Publication
Authors
C. Waterman, R.P. Castro
Keywords
moringa, health claims, Brazil, European Union, regulations
Groups involved
Online Articles (47)